5UZJ | pdb_00005uzj

Crystal Structure of ROCK1 bound to an aminopyridine inhibitor

• PDB DOI: https://doi.org/10.2210/pdb5UZJ/pdb

• Classification: Transferase/Transferase Inhibitor
• Organism(s): Homo sapiens
• Expression System: Spodoptera frugiperda
• Mutation(s): No 


• Deposited: 2017-02-26 Released: 2018-03-07 
• Deposition Author(s): Jacobs, M.D.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 3.30 Å
• R-Value Free: 
  0.241 (Depositor), 0.238 (DCC) 
• R-Value Work: 
  0.200 (Depositor) 
• R-Value Observed: 
  0.202 (Depositor) 

Starting Model: experimental

Literature

ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitors.

Bandarage, U.K., Cao, J., Come, J.H., Court, J.J., Gao, H., Jacobs, M.D., Marhefka, C., Nanthakumar, S., Green, J.

(2018) Bioorg Med Chem Lett 28: 2622-2626

• PubMed: 30082069 
• DOI: https://doi.org/10.1016/j.bmcl.2018.06.040
• Primary Citation Related Structures: 
  5UZJ, 5UZK


• PubMed Abstract: 
  

  Rho kinase (ROCK) inhibitors are potential therapeutic agents for the treatment of a variety of disorders including hypertension, glaucoma and erectile dysfunction. Here we disclose a series of potent and selective ROCK inhibitors based on a substituted 7-azaindole scaffold. Substitution of the 3-position of 7-azaindole led to compounds such as 37, which possess excellent ROCK inhibitory potency and high selectivity against the closely related kinase PKA.

---

Organizational Affiliation: 
• Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210, USA. Electronic address: [e-mail].
Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210, USA.
Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210, USA. Electronic address: [e-mail].

Biological Assembly 1  

Global Symmetry: Cyclic - C2  (Explore in 3D)
Global Stoichiometry: Homo 2-mer - A2 

Biological assembly 1 assigned by authors and generated by PISA (software)

Biological Assembly Evidence: equilibrium centrifugation

Macromolecule Content 

• Total Structure Weight: 96.71 kDa 
• Atom Count: 6,352 
• Modeled Residue Count: 773 
• Deposited Residue Count: 830 
• Unique protein chains: 1

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Rho-associated protein kinase 1	A, B	415	Homo sapiens	Mutation(s): 0  Gene Names: ROCK1 EC: 2.7.11.1 (PDB Primary Data), 2.7.11.39 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for Q13464 (Homo sapiens) Explore Q13464  Go to UniProtKB:  Q13464
PHAROS:  Q13464 GTEx:  ENSG00000067900

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
8UV	C [auth A], D [auth B]	N-[4-(2-aminopyridin-4-yl)-1,3-thiazol-2-yl]-2-(3-methoxyphenyl)acetamide C17 H16 N4 O2 S HIGGJLMBFDDVKA-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 3.30 Å
• R-Value Free:  0.241 (Depositor), 0.238 (DCC) 
• R-Value Work:  0.200 (Depositor) 
• R-Value Observed: 0.202 (Depositor) 

Space Group: P 3₁ 2 1

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 183.97	α = 90
b = 183.97	β = 90
c = 91.64	γ = 120

Software Package:

Software Name	Purpose
d*TREK	data collection
d*TREK	data scaling
BUSTER	refinement
PDB_EXTRACT	data extraction
d*TREK	data reduction

Structure Validation

Entry History 

Deposition Data

• Released Date: 2018-03-07 
Deposition Author(s): Jacobs, M.D.

Revision History  

• Version 1.0: 2018-03-07
  Type: Initial release
  
• Version 1.1: 2018-07-11
  Changes: Data collection, Database references
• Version 1.2: 2018-08-22
  Changes: Data collection, Database references
• Version 1.3: 2023-10-04
  Changes: Data collection, Database references, Refinement description